Optimising metabolic outcomes using glp-1 receptor agonist therapy in severe obesity and poorly controlled diabetes mellitus

B, Nur Haziqah and M, Aimi Fadilah and Ew, Nur Aini and A, Mohd Hazriq and Ms, Fatimah Zaherah and Ag, Rohana (2026) Optimising metabolic outcomes using glp-1 receptor agonist therapy in severe obesity and poorly controlled diabetes mellitus. Journal of Clinical and Health Sciences (JCHS), 11 (SUPP2). pp. 42-43. ISSN 0127-984X

Official URL: https://jchs-medicine.uitm.edu.my

Abstract

Glucagon-like peptide-1 (GLP-1)–based therapies have emerged as an important therapeutic modality in the management of obesity and type 2 diabetes mellitus. Optimisation of GLP-1 therapy has been shown to result in substantial reductions in HbA1c, improved lipid profiles, and meaningful reductions in body weight.

Item Details

Item Type:	Article
Creators:	Creators Email / ID Num. B, Nur Haziqah chika2187@gmail.com M, Aimi Fadilah UNSPECIFIED Ew, Nur Aini UNSPECIFIED A, Mohd Hazriq UNSPECIFIED Ms, Fatimah Zaherah UNSPECIFIED Ag, Rohana UNSPECIFIED
Subjects:	R Medicine > RC Internal Medicine > Specialties of internal medicine > Metabolic diseases > Obesity R Medicine > RC Internal Medicine > Diabetes Mellitus
Divisions:	Universiti Teknologi MARA, Selangor > Sungai Buloh Campus > Faculty of Medicine
Journal or Publication Title:	Journal of Clinical and Health Sciences (JCHS)
ISSN:	0127-984X
Event Title:	2nd National Obesity Scientific Conference
Event Dates:	11th - 12th April 2026
Volume:	11
Number:	SUPP2
Page Range:	pp. 42-43
Keywords:	GLP-1 receptor agonists, Severe obesity, Poorly controlled diabetes mellitus, Type 2 diabetes mellitus, Metabolic outcomes, Glycemic control, Weight management
Date:	September 2026
URI:	https://ir.uitm.edu.my/id/eprint/147605

: Edit Item

Downloads & Files

Text
147605.pdf

Download (226kB)

Indexing & Metrics